InvestorsHub Logo
Followers 10
Posts 778
Boards Moderated 0
Alias Born 03/18/2003

Re: Jonjones325 post# 88661

Tuesday, 01/24/2017 4:50:45 PM

Tuesday, January 24, 2017 4:50:45 PM

Post# of 459610

So I guess we can take this to mean Anavex is funding the Alz trial on its own. Or at least hopes to. 17!million. Proababy not enough. Where's the money coming from then? Missling knows. We have all made a few guesses. All quite possible.

Waiting until commercialization of proven success to get a partner means Missling doesn't want to give away the company or pieces of it if he doesn't have to. This speaks to his confidence in running a successful trial. No help needed. Thanks but we got this one.


Yes, Dr Misslings response raises some interesting questions and your conjecture is as good as anyone's. It seems like Anavex is pursuing quite an unorthodox path to success. Perhaps they think they can achieve their goal piecemeal, with smaller successes (Australian funded p3 success, or Rett organization funded p2 success) leading to funding and eventual FDA approval in the USA. Otherwise stock dilution? Who knows? But, as long as the drug works, it wont matter much.

IMHO
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News